Aigenpulse is our new state of-the-art data intelligence platform which is designed to help you to expedite the drug discovery and development process. By harnessing the latest artificial intelligence and machine learning tools, it delivers advanced data analytics to underpin scientific decision making.

Built specifically for the R&D enterprise, the Aigenpulse Platform unifies silos promoting data re-use​, provides automated processing, analysis and report templating, offers in-built statistics, visualisation and machine learning tools​, enabling high-quality outputs to be generated at multiple stages of the R&D life cycle.​

There is no other enterprise data analytics SaaS solution suited to the life sciences quite like the Aigenpulse Platform. Our clearly differentiated approach is focussed around three key customer value drivers: reuse, quality and efficiency.

The Aigenpulse Platform lowers the barrier to entry to digital transformation and is an enabling technology for users to leverage true machine learning on their organisation’s data, augmented with public and external assets.

Aigenpulse blends biotechnology and data analytics to drive your research further

Unlock the power of your data
Aigenpulse is the intelligence platform for Life Sciences. It is configurable and modular, and continuously adapts to the unique research requirements and structures of your organisation.
Powerful and scalable
The Aigenpulse Platform enables the integration of multi-omics R&D and clinical data to support high quality decision making in a secure, audited and scalable environment.
Data science and machine learning
The Aigenpulse Platform provides a low barrier to entry for advanced analytics and machine learning, facilitating high powered analysis to underpin more scientific research.

Expedite your drug discovery process